IVF Disrupted: The Kindbody Story
By Jackie Davalos,
Bloomberg
| 09. 15. 2025
An investigation into clinical mistakes, staffing crises, and financial pressures at one of America's fastest-growing IVF chains.
Kindbody, one of the largest fertility companies in the US, sought to disrupt egg freezing and IVF by combining spa vibes with Silicon Valley efficiency. The startup raised millions, opened dozens of clinics, and became a billion-dollar unicorn. But its ambition came with consequences. In IVF Disrupted: The Kindbody Story, reporter Jackie Davalos takes listeners beyond Kindbody’s millennial-friendly waiting rooms and into the clinics themselves, showing the sometimes-heartbreaking consequences of bringing the “move fast and break things” mentality to the business of creating life.
Episode 1
The Fertility Spa
In 2018 a startup emerged, aiming to revolutionize fertility care with spa-like clinics and Silicon Valley swagger. Kindbody attracted millions from investors eager to disrupt a booming industry. But former employees describe a company that at times cut too many corners as it raced to expand. In this episode, reporter Jackie Davalos investigates what can happen when startup culture collides with the delicate science of creating life.
Episode 2
The Embryo Mixup
Dina and B arrive at Kindbody for the embryo transfer they’ve dreamed about for years. But their doctor delivers...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...